Other
Drug Facts
The following Structured Product Label (SPL) was submitted to the FDA by Reckitt Benckiser Llc for the product Mucinex (NDC 63824-008). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding other, active ingredient (in each extended-release tablet), purpose, uses, do not use, ask a doctor before use if you have, stop use and ask a doctor if, otc - pregnancy or breast feeding, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Drug Facts
Guaifenesin 600 mg
Expectorant
If pregnant or breast-feeding,ask a health professional before use.
Keep out of reach of children.In case of overdose, get medical help or contact a Poison Control Center right away.
carbomer homopolymer type B; FD&C blue no. 1 aluminum lake; hypromellose, USP; magnesium stearate, NF; microcrystalline cellulose, NF; sodium starch glycolate, NF
1-866-MUCINEX (1-866-682-4639)
NDC 63824-008-32
Mucinex®
600 mg guaifenesin
extended-release tablets
EXPECTORANT
12
HOUR
®
✓ Relieves Chest Congestion
✓ Thins and Loosens Mucus
✓ Immediate and Extended Release
20
EXTENDED-RELEASE TABLETS
* Please review the disclaimer below.